CARTILAGE DEVELOPMENT DISORDER

CARTILAGE DEVELOPMENT DISORDER was reported 17 times

CARTILAGE DEVELOPMENT DISORDER is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 SUMATRIPTAN SUCCINATE AND NAPROXEN SODIUM 1 0.0007
1 BOTULINUM TOXIN TYPE A 2 0.0002
2 BUTALBITAL, ACETAMINOPHEN, AND CAFFEINE 1 0.0001
3 ZONISAMIDE 1 0.0001
4 AMPHOTERICIN B 1 0.0001
5 EXTENDED PHENYTOIN SODIUM 1 0.0001
6 DORNASE ALFA 1 0.0001
7 RISEDRONATE SODIUM 1 0.0000
8 SOMATROPIN 2 0.0000
9 SUMATRIPTAN 1 0.0000
10 TERIPARATIDE 2 0.0000
11 MYCOPHENOLATE MOFETIL 2 0.0000
12 HYDROXYCHLOROQUINE SULFATE 1 0.0000
13 POTASSIUM CHLORIDE 1 0.0000
14 SERTRALINE HYDROCHLORIDE 1 0.0000
15 TACROLIMUS OINTMENT 0.1% 1 0.0000
16 TACROLIMUS EXTENDED-RELEASE CAPSULES 1 0.0000
17 LAMOTRIGINE 1 0.0000
18 LEVETIRACETAM 1 0.0000
19 TACROLIMUS 1 0.0000
20 OMEPRAZOLE MAGNESIUM 1 0.0000
21 PREDNISONE 1 0.0000
22 DUPILUMAB 1 0.0000
23 ETANERCEPT 1 0.0000
24 ADALIMUMAB 1 0.0000